Delivering novel targets and antibiotics from genomics

Current Opinion in Investigational Drugs

Volumn 2, Issue 8, 2001, Pages 1028-1034

  Payne, D J ^a   Holmes, D J ^a   Rosenberg, M ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

Bacterial genomics; Bioinformatics; Chorismate biosynthesis; ERNA synthetases; Essentiality testing; Fatty acid biosynthesis; FtsA; FtsZ; Isoprenoid biosynthesis; MurA; Two component signal transduction systems

Indexed keywords

ANTIBIOTIC AGENT; CHORISMATE MUTASE; FATTY ACID; FLUINDOSTATIN; FOSFOMYCIN; GENE PRODUCT; ISOPRENOID; PSEUDOMONIC ACID; SYNTHETASE; TRANSFER RNA METHYLTRANSFERASE;

BACTERIAL GROWTH; BACTERIOLOGY; BACTERIUM; BIOTECHNOLOGY; CELL DIVISION; DNA SEQUENCE; DRUG INFORMATION; DRUG SCREENING; DRUG SYNTHESIS; DRUG TARGETING; FATTY ACID SYNTHESIS; GENE; GENOME; MUTAGENESIS; NONHUMAN; PATHOGENICITY; PHARMACOGENOMICS; PLASMID; REVIEW; SIGNAL TRANSDUCTION; VALIDATION PROCESS;

ANTI-BACTERIAL AGENTS; BACTERIA; COMPUTATIONAL BIOLOGY; GENE TARGETING; GENOMICS;

EID: 0034887256     PISSN: 09678298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Hospital-acquired infections: Diseases with increasingly limited therapies
2. A genomic perspective on protein families
3. A genome-based approach for the identification of essential bacterial genes
4. The sequence of the human genome
5. Initial sequencing and analysis of the human genome
6. Simultaneous identification of bacterial virulence genes by negative selection
7. Identification of Staphylococcus aureus virulence genes in a murine model of bacteraemia using signature-tagged mutagenesis
8. Use of genomics to identify bacterial undecaprenyl pyrophosphate synthetase: Cloning, expression and characterization of the essential uppS gene
9. DNA sequence sampling of the Streptococcus pneumoniae genome to identify novel targets for antibiotic development
10. Analysis of a second bacteriophage hyaluronidase gene from Streptococcus pyogenes: Evidence for a third hyaluronidase involved in extracellular enzymatic activity
11. Sequence and mapping of the aroA gene of Staphylococcus aureus 8325-4
12. Regulated expression of heterologous genes in Bacillus subtilis using the Tn10 encoded tet regulatory elements
13. Integrational plasmids for the tetracycline-regulated expression of genes in Streptococcus pneumoniae
14. Regulated gene expression in Staphylococcus aureus for identifying conditional lethal phenotypes and antibiotic mode of action
15. Regulated antisense RNA eliminates α-toxin virulence in Staphylococcus aureus infection
16. Identification of essential genes in Staphylococcus aureus using inducible antisense RNA
17. The impact of genomics on novel antibacterial targets
18. Two active forms of UDP-N-acetylglucosamine enolpyruvyl transferase in gram-positive bacteria
19. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd
20. The complete genome sequence of the gastric pathogen Helicobacter pylori
21. A genomic analysis of two-component signal transduction in Streptococcus pneumoniae
22. FtsA is localized to the septum in an FtsZ-dependent manner
23. A conserved residue at the extreme C-terminus of FtsZ is critical for the FtsA-FtsZ interaction in Staphylococcus aureus
24. Genetic and functional analyses of the conserved C-terminal core domain of Escherichia coli FtsZ
25. Identification, evolution and essentiality of the mevalonate pathway for isopretentyl diphosphate biosynthesis in gram positive cocci
26. Essentiality, expression and characterization of the class II 3-hydroxy-3-methylglutaryl coenzyme A reductase of Staphylococcus aureus
27. Bacterial fatty-acid biosynthesis: A genomics driven target for antibacterial drug discovery
28. Inhibitors of bacterial enoyl acyl carrier protein reductase (Fabl): 2,9-Disubstituted 1,2,3,4-tetrahydropyrido[3,4-b]indoles as potential antibacterial agents
29. 1,4-Disubstituted imidazoles are potential antibacterial agents functioning as inhibitors of enoyl acyl carrier protein reductase (Fabl)
30. Validation of drug target by regulated antisense RNA in Staphylococcus aureus